Daptomycin treatment failure for vancomycin-resistant Enterococcus faecium infective endocarditis:: Impact of protein binding?

被引:28
作者
Schwartz, Brian S. [1 ]
Ngo, Penny D. [2 ]
Guglielmo, B. Joseph [3 ]
机构
[1] Univ Calif San Francisco SFGH, Div Infect Dis, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Pharm, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Clin Pharm, San Francisco, CA 94143 USA
关键词
D O I
10.1345/aph.1K548
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:289 / 290
页数:2
相关论文
共 6 条
[1]  
[Anonymous], 2007, PACK INS CUB DAPT
[2]   Daptomycin: Another novel agent for treating infections due to drug-resistant gram-positive pathogens [J].
Carpenter, CF ;
Chambers, HF .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (07) :994-1000
[3]   EFFECT OF PROTEIN-BINDING OF DAPTOMYCIN ON MIC AND ANTIBACTERIAL ACTIVITY [J].
LEE, BL ;
SACHDEVA, M ;
CHAMBERS, HF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (12) :2505-2508
[4]   Differential increased survival of staphylococci and limited ultrastructural changes in the core of infected fibrin clots after daptomycin administration [J].
Michiels, MJ ;
Bergeron, MG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (01) :203-211
[5]   In vivo pharmacodynamic activity of daptomycin [J].
Safdar, N ;
Andes, D ;
Craig, WA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (01) :63-68
[6]   Daptomycin for the treatment of gram-positive bacteremia and infective endocarditis: A retrospective case series of 31 patients [J].
Segreti, JA ;
Crank, CW ;
Finney, MS .
PHARMACOTHERAPY, 2006, 26 (03) :347-352